Apr 03, 2020
Nuclear Factor Erythroid 2 Related Factor 2 Pipeline & Therapeutics Landscape, 2020
Dec 17, 2019
Kanazawa University Research: Possible Strategy for Cancer Treatment Found in Nuclear Transport Proteins
Dec 09, 2019
Syndax Announces Preclinical Results Supporting Development of its Portfolio of Menin Inhibitors In Mixed Lineage Leukemias
Nov 06, 2019
Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias
Nov 04, 2019
Okayama University Research: Synthetic Compound Provides Fast Screening For Potential Drugs
Jun 27, 2019
Too Many Antioxidants May Cause Lung Cancer Spread
Jun 24, 2019
New Satellite Cell Exercise Recovery Research on NuLiv Science's ActiGin® Published
May 17, 2019
Countries Around the World to Shine a Light on NF on May 17, World NF Awareness Day
Mar 14, 2019
The Fight Against Cancer: The Promise of HIF-1 Inhibitors
Feb 27, 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Feb 07, 2019
In Honor of Kids with Tumors, Wear Blue and Green on May Seventeen
Dec 19, 2018
Ascentage Pharma Announces Strategic Collaboration with Genor Biopharma
Dec 03, 2018
Syndax Pharmaceuticals Announces Presentation of Preclinical Data from Menin-MLL Program at the 60th American Society of Hematology Annual Meeting
Nov 30, 2018
Aprea Therapeutics Closes EUR 50 Million Financing
Nov 13, 2018
HOX Therapeutics Appoints Karl Keegan as Chief Executive Officer
Nov 01, 2018
Syndax Pharmaceuticals Announces Presentations at the 60th American Society of Hematology Annual Meeting
Oct 23, 2018
New Kind of Compound Shows Early Promise against Prostate Cancer
Aug 14, 2018
Actavalon Announces Appointments of Dr. John Hood to Its Board of Directors
Aug 06, 2018
Scientist.com and Orphagen Pharmaceuticals Partner to Offer Online Access to Nuclear Receptor Profiling and Screening Services
Apr 19, 2018
Welbilt Completes Crem International Acquisition